EU registry of cornea transplants up and running
Data on 12,612 transplants from 12 countries already submitted for review


Priscilla Lynch
Published: Sunday, September 15, 2019
[caption id="attachment_16621" align="alignleft" width="1024"]
Jesper Hjortdal and Mats Lundström, who presented an update on the ECCTR Registry[/caption]
THE European Cornea and Cell Transplantation Registry (ECCTR) is now up and running successfully, with data on 12,612 transplants from 12 countries already submitted for review, according to an update session during the EuCornea Congress yesterday.
The aim of the ECCTR is to build a common assessment methodology and establish an EU web-based registry and network for academics, health professionals and authorities to assess and verify the safety, quality and efficacy of corneal transplantation in ophthalmic surgery.
The registry is recording recipient characteristics, donor and eye bank processing data and transplant procedure information, with a two-year follow-up including survival, outcomes and complications.
To date, most recipients are between 70 and 79 years of age, with Fuchs’ dystrophy the leading indication for transplantation.
The project is a three-year programme, with evaluation and dissemination of the collected data and development of a European protocol to follow once recruitment of clinics is complete.
Speaking to EuroTimes, EuCornea President Jesper Hjortdal said he was pleased with the uptake so far, with more European countries now due to join, and others expressing an interest in engaging.

Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.